No immediate plans for further stake sales or Biocon Biologics IPO: CEO Siddharth Mittal

June 23, 2025
Uncategorized

Siddharth Mittal, CEO & MD of Biocon says the company will evaluate Biologics IPO after committee review; current focus is on servicing private equity and structured obligations.

No immediate plans for further stake sales or Biocon Biologics IPO: CEO Siddharth Mittal

Leave a ReplyCancel Reply

GMR Airports Q3 net profit drops 54% despite strong revenue growth

Galaxy Surfactants Q3 net profit falls 9% as performance surfactants segment softens

RBI lets banks fund company buyouts, opening a new era for big corporate deals

Azad Engineering Q3 profit jumps 44% on 33% segment growth, margin expands to 39%

Ola Electric employee costs surge in December quarter; net loss exceeds revenue